All Stories

  1. Unveiling the hidden risks of human exposure to nanomedicine and nanopollutants: Nanoparticle-induced blood barrier disruption and tissue toxicity

    Article • Colloids and Surfaces B Biointerfaces, November 2025, Elsevier

    Dr. Nima Sanadgol

  2. Role of extracellular vesicle-carried ncRNAs in the interactive ‘dialogue’ within the brain and beyond: emerging theranostic epigenetic modifiers in brain-derived nanoplatforms

    Article • Translational Neurodegeneration, August 2025, Springer Science + Business Media

    Dr. Nima Sanadgol

  3. Dynamics and role of covalently-closed circular RNAs in Alzheimer's disease: A review of experimental and bioinformatics studies

    Article • Neurobiology of Aging, July 2025, Elsevier

    Dr. Nima Sanadgol

  4. Genomic ncRNAs regulating mitochondrial function in neurodegeneration: a neglected clue in the complex etiopathogenesis of multiple sclerosis

    Article • Cell & Bioscience, June 2025, Springer Science + Business Media

    Dr. Nima Sanadgol

  5. Genomic ncRNAs Regulating Mitochondrial Function in Neurodegeneration: A Neglected Clue in the Complex Etiopathogenesis of Multiple Sclerosis

    Article • May 2025, Springer Science + Business Media

    Dr. Nima Sanadgol

  6. Mitochondrial genome-derived circRNAs: Orphan epigenetic regulators in molecular biology

    Article • Mitochondrion, November 2024, Elsevier

    Dr. Nima Sanadgol

  7. Role of Circular RNA MMP9 in Glioblastoma Progression: From Interaction With hnRNPC and hnRNPA1 to Affecting the Expression of BIRC5 by Sequestering miR‐149

    Article • Journal of Molecular Recognition, October 2024, Wiley

    Dr. Nima Sanadgol

  8. Presenilin-1-Derived Circular RNAs: Neglected Epigenetic Regulators with Various Functions in Alzheimer’s Disease

    Article • Biomolecules, September 2023, MDPI AG

    Dr. Nima Sanadgol

  9. TNF-α/STAT1/CXCL10 mutual inflammatory axis that contributes to the pathogenesis of experimental models of multiple sclerosis: A promising signaling pathway for targeted therapies

    Article • Cytokine, August 2023, Elsevier

    Dr. Nima Sanadgol

  10. Lipocalin-2 Deficiency Diminishes Canonical NLRP3 Inflammasome Formation and IL-1β Production in the Subacute Phase of Spinal Cord Injury

    Article • International Journal of Molecular Sciences, May 2023, MDPI AG

    Dr. Nima Sanadgol

  11. The interplay between tauopathy and aging through interruption of UPR/Nrf2/autophagy crosstalk in the Alzheimer’s disease transgenic experimental models

    Article • International Journal of Neuroscience, May 2023, Taylor & Francis

    Dr. Nima Sanadgol

  12. MAPK Is a Mutual Pathway Targeted by Anxiety-Related miRNAs, and E2F5 Is a Putative Target for Anxiolytic miRNAs

    Article • Biomolecules, March 2023, MDPI AG

    Dr. Nima Sanadgol

  13. Prophylactic effects of cucurbitacin B in the EAE Model of multiple sclerosis by adjustment of STAT3/IL-23/IL-17 axis and improvement of neuropsychological symptoms

    Article • Metabolic Brain Disease, October 2022, Springer Science + Business Media

    Dr. Nima Sanadgol

  14. Neuroprotective effect of the Nrf2/ARE/miRNA145-5p signaling pathway in the early phase of spinal cord injury

    Article • Life Sciences, September 2022, Elsevier

    Dr. Nima Sanadgol

  15. LncRNA‐miRNA network analysis across the Th17 cell line reveals biomarker potency of lncRNA NEAT1 and KCNQ1OT1 in multiple sclerosis

    Article • Journal of Cellular and Molecular Medicine, March 2022, Wiley

    Dr. Nima Sanadgol

  16. An Updated Review of Various Medicinal Applications of p-Co umaric Acid: From Antioxidative and Anti-Inflammatory Properties to Effects on Cell Cycle and Proliferation

    Article • Mini-Reviews in Medicinal Chemistry, November 2021, Bentham Science Publishers

    Dr Hamed Haghi-Aminjan, Karim Daliri, Dr. Nima Sanadgol

  17. Age and Dose-Dependent Effects of Alpha-Lipoic Acid on Human Microtubule- Associated Protein Tau-Induced Endoplasmic Reticulum Unfolded Protein Response: Implications for Alzheimer’s Disease

    Article • CNS & Neurological Disorders - Drug Targets, November 2021, Bentham Science Publishers

    Dr. Nima Sanadgol, Gholamhassan Vaezi

  18. The Association Between Fennel Extract, Serum Lipid Profile, and Leptin Receptor Expression

    Article • Basic and Clinical Neuroscience Journal, November 2021, Negah Scientific Publisher

    Dr. Nima Sanadgol

  19. Construction of a lncRNA–miRNA–mRNA Network to Determine the Key Regulators of the Th1/Th2 Imbalance in Multiple Sclerosis

    Article • Epigenomics, November 2021, Taylor & Francis

    Dr. Nima Sanadgol

  20. Alpha‐lipoic acid ameliorates tauopathy‐induced oxidative stress, apoptosis, and behavioral deficits through the balance of DIAP1/DrICE ratio and redox homeostasis: Age is a determinant factor

    Article • Metabolic Brain Disease, February 2021, Springer Science + Business Media

    Dr. Nima Sanadgol

  21. Age and dose-dependent effects of alpha-lipoic acid on human microtubule-associated protein tau-induced endoplasmic reticulum unfolded protein response: implications for Alzheimer’s disease

    Article • August 2020, Cold Spring Harbor Laboratory Press

    Dr. Nima Sanadgol

  22. Mechanisms and pathogenesis underlying environmental chemical-induced necroptosis

    Article • Environmental Science and Pollution Research, July 2020, Springer Science + Business Media

    Dr. Nima Sanadgol

  23. A Systematic Review of Current Progresses in The Nucleic Acid-Based Therapies for Neurodegeneration with Implications for Alzheimer’s disease

    Article • Mini-Reviews in Medicinal Chemistry, May 2020, Bentham Science Publishers

    Prof Mohammad Abdollahi, Dr. Nima Sanadgol

  24. Recent updates in the Alzheimer’s disease etiopathology and possible treatment approaches: a narrative review of current clinical trials

    Article • Current Molecular Pharmacologye, April 2020, Bentham Science Publishers

    Dr. Nima Sanadgol, Gholamhassan Vaezi

  25. Oral microbiota and Alzheimer’s disease: Do all roads lead to Rome?

    Article • Pharmacological Research, January 2020, Elsevier

    Professor HAROON N KHAN, Dr. Nima Sanadgol, Prof. Antoni Sureda

  26. Metformin accelerates myelin recovery and ameliorates behavioral deficits in the animal model of multiple sclerosis via adjustment of AMPK/Nrf2/mTOR signaling and maintenance of endogenous oligodendrogenesis during brain self-repairing period

    Article • Pharmacological Reports, December 2019, Springer Science + Business Media

    Dr. Nima Sanadgol

  27. On the Neuroprotective Effects of Naringenin: Pharmacological Targets, Signaling Pathways, Molecular Mechanisms, and Clinical Perspective

    Article • Biomolecules, November 2019, MDPI AG

    Dr. Nima Sanadgol

  28. Metformin-induced AMPK activation stimulates remyelination through induction of neurotrophic factors, downregulation of NogoA and recruitment of Olig2+ precursor cells in the cuprizone murine model of multiple sclerosis

    Article • DARU Journal of Pharmaceutical Sciences, October 2019, Springer Science + Business Media

    Dr. Nima Sanadgol

  29. Sepantronium Bromide (YM155), A Small Molecule Survivin Inhibitor, Promotes Apoptosis by Induction of Oxidative Stress, Worsens the Behavioral Deficits and Develops an Early Model of Toxic Demyelination: In Vivo and In-Silico Study

    Article • Neurochemical Research, September 2019, Springer Science + Business Media

    Dr. Nima Sanadgol

  30. Melatonin and Multiple Sclerosis: From Plausible Neuropharmacological Mechanisms of Action to Experimental and Clinical Evidence

    Article • Clinical Drug Investigation, May 2019, Springer Science + Business Media

    Dr. Nima Sanadgol

  31. Investigation of association between CD40 current gene variants (rs4810485, rs1883832 and rs3765459) and serum CD154 protein levels in Iranian migraineurs

    Article • Cellular and Molecular Biology, November 2018, CMB Association

    Dr. Nima Sanadgol

  32. The role of nitric oxide signaling in renoprotective effects of hydrogen sulfide against chronic kidney disease in rats: Involvement of oxidative stress, autophagy and apoptosis

    Article • Journal of Cellular Physiology, November 2018, Wiley

    Dr. Nima Sanadgol

  33. Ameliorative effects of hydrogen sulfide (NaHS) on chronic kidney disease-induced brain dysfunction in rats: implication on role of nitric oxide (NO) signaling

    Article • Metabolic Brain Disease, August 2018, Springer Science + Business Media

    Dr. Nima Sanadgol

  34. Immunomodulatory effects of a rationally designed peptide mimetic of human IFNβ in EAE model of multiple sclerosis

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, March 2018, Elsevier

    Dr. Nima Sanadgol

  35. Low, but not high, dose triptolide controls neuroinflammation and improves behavioral deficits in toxic model of multiple sclerosis by dampening of NF-κB activation and acceleration of intrinsic myelin repair

    Article • Toxicology and Applied Pharmacology, March 2018, Elsevier

    Dr. Nima Sanadgol

  36. Acetyl-l-Carnitine Attenuates Arsenic-Induced Oxidative Stress and Hippocampal Mitochondrial Dysfunction

    Article • Biological Trace Element Research, November 2017, Springer Science + Business Media

    Dr. Nima Sanadgol

  37. Evaluation of metformin effects in the chronic phase of spontaneous seizures in pilocarpine model of temporal lobe epilepsy

    Article • Metabolic Brain Disease, October 2017, Springer Science + Business Media

    Dr. Nima Sanadgol

  38. Alpha-lipoic acid mitigates toxic-induced demyelination in the corpus callosum by lessening of oxidative stress and stimulation of polydendrocytes proliferation

    Article • Metabolic Brain Disease, October 2017, Springer Science + Business Media

    Dr. Nima Sanadgol

  39. Recent Updates in Imperative Natural Compounds for Healthy Brain and Nerve Function: A Systematic Review of Implications for Multiple Sclerosis

    Article • Current Drug Targets, September 2017, Bentham Science Publishers

    Dr. Nima Sanadgol

  40. Molecular evidence on the protective effect of ellagic acid on phosalone-induced senescence in rat embryonic fibroblast cells

    Article • Food and Chemical Toxicology, February 2017, Elsevier

    Dr. Nima Sanadgol

  41. Neuroprotective effects of ellagic acid on cuprizone-induced acute demyelination through limitation of microgliosis, adjustment of CXCL12/IL-17/IL-11 axis and restriction of mature oligodendrocytes apoptosis

    Article • Pharmaceutical Biology, January 2017, Taylor & Francis

    Dr. Nima Sanadgol

  42. Depressed Immune Responses and Accelerated Splenic Apoptosis due to Experience of Food Deprivation and Inequality but not Unstable Social Status in Balb/c Mice

    Article • NeuroImmunoModulation, January 2017, Karger Publishers

    Dr. Nima Sanadgol

  43. Association between interleukin-4 (IL-4), gene polymorphisms (C-589T, T+2979G, and C-33T) and migraine susceptibility in Iranian population: A case–control study

    Article • Egyptian Journal of Medical Human Genetics, January 2017, Springer Science + Business Media

    Dr. Nima Sanadgol

  44. A highly specific and sensitive loop-mediated isothermal amplification method for the detection of Escherichia coli O157:H7

    Article • Microbial Pathogenesis, February 2016, Elsevier

    Dr. Nima Sanadgol

  45. Prophylactic Effect of BIO-1211 Small-Molecule Antagonist of VLA-4 in the EAE Mouse Model of Multiple Sclerosis

    Article • Immunological Investigations, October 2015, Taylor & Francis

    Dr. Nima Sanadgol

  46. Transforming growth factor beta-1 (TGF-β1) gene single nucleotide polymorphisms (SNPs) and susceptibility to pre-eclampsia in Iranian women: A case–control study

    Article • Pregnancy Hypertension, October 2015, Elsevier

    Dr. Nima Sanadgol

  47. Human Cytomegalovirus in Oral Squamous Cell Carcinoma in Southeast of Iran

    Article • Jundishapur Journal of Microbiology, August 2015, Kowsar Medical Institute

    Dr. Nima Sanadgol

  48. The analysis of correlation between IL-1B gene expression and genotyping in multiple sclerosis patients

    Article • Journal of the Neurological Sciences, August 2014, Elsevier

    Dr. Nima Sanadgol

  49. TLR9: an important molecule in the fight against hepatitis B virus

    Article • Postgraduate Medical Journal, June 2014, BMJ

    Dr. Nima Sanadgol

  50. Relationship between metalloproteinase 2 and 9 concentrations and soluble CD154 expression in Iranian patients with multiple sclerosis

    Article • The Kaohsiung Journal of Medical Sciences, May 2014, Wiley

    Dr. Nima Sanadgol

  51. Methicillin-resistance Staphylococcus aureus in Southeast Iran: Herbal Control and Detection Methods Comparison

    Article • Journal of Medical Sciences(Faisalabad), March 2014, Science Alert

    Moj Khaleghi, Dr. Nima Sanadgol

  52. CCR5 Plays Important Roles in Hepatitis B Infection

    Article • Viral Immunology, February 2014, Mary Ann Liebert Inc

    Dr. Nima Sanadgol

  53. Epidermal growth factor receptor gene expression evaluation in colorectal cancer patients

    Article • Indian Journal of Cancer, January 2014, Medknow

    Dr. Nima Sanadgol

  54. Strategies for optimizing DNA hybridization on surfaces

    Article • Analytical Biochemistry, January 2014, Elsevier

    Dr. Nima Sanadgol

  55. Isolation and Characterization of CPRgene Promoter from Artemisia annua by Thermal Asymmetric Interlaced Polymerase Chain Reaction (TAIL-PCR)

    Article • American Journal of Biochemistry and Molecular Biology, September 2013, Science Alert

    Dr. Nima Sanadgol

  56. Association of VCAM-1 Gene Polymorphisms with Multiple Sclerosis Susceptibility in the Southeast of Iran

    Article • American Journal of Biochemistry and Molecular Biology, June 2013, Science Alert

    Dr. Nima Sanadgol

  57. Evaluation of reactive Epstein–Barr Virus (EBV) in Iranian patient with different subtypes of multiple sclerosis (MS)

    Article • The Brazilian Journal of Infectious Diseases, March 2013, Elsevier

    Dr. Nima Sanadgol

  58. Monitoring of Active Human Herpes Virus 6 Infection in Iranian Patients with Different Subtypes of Multiple Sclerosis

    Article • Journal of Pathogens, January 2013, Hindawi Publishing Corporation

    Dr. Nima Sanadgol

  59. Effect of palmitic acid and linoleic acid on expression of ICAM-1 and VCAM-1 in human bone marrow endothelial cells (HBMECs)

    Article • Archives of Medical Science, January 2012, Termedia Sp. z.o.o.

    Dr. Nima Sanadgol

  60. Elaidic acid sustains LPS and TNF-α induced ICAM-1 and VCAM-I expression on human bone marrow endothelial cells (HBMEC)

    Article • Clinical Biochemistry, August 2010, Elsevier

    Dr. Nima Sanadgol

  61. Fluid Therapy in Pediatric Victims of the 2003 Bam, Iran Earthquake

    Article • Prehospital and Disaster Medicine, October 2009, Cambridge University Press

    Dr. Nima Sanadgol